Switching From Tenofovir Disoproxil Fumarate And/Or Other Oral Antivirals To Tenofovir Alafenamide In Virally Suppressed Chronic Hepatitis B Patients With Hepatic Impairment: Final 2 Year Efficacy And Safety Results From A Phase 2, Open-Label Study